Breaking News, Promotions & Moves

Nuclera Welcomes Joseph Bertelsen as Chief Commercial Officer

Bertelsen’s sales record will be instrumental to the commercial launch strategy and adoption of Nuclera’s eProtein Discovery platform.

Author Image

By: Charlie Sternberg

Associate Editor

Nuclera, a biotechnology company, has appointed Joseph Bertelsen as Chief Commercial Officer (CCO). Experience With over 20 years’ commercial leadership experience in the life science tools and drug development industries, Bertelsen brings an extensive sales record that will be instrumental to the commercial launch strategy and adoption of Nuclera’s eProtein Discovery platform.   Bertelsen joins Nuclera from the Institute for Protein Innovation, a research institute focused on providing s...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters